EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS
El Batanouny, M., M. Essawy, M., Ezzat, H., Abbas, M., M. Nosseir, M., S. Omran, Z., A. Khaled, I. (2001). EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS. EKB Journal Management System, 20(4), 722-728. doi: 10.21608/ejsur.2001.375850
M El Batanouny; Mohamed M. Essawy; Hussein Ezzat; Mohamed Abbas; Mona M. Nosseir; Zainab S. Omran; Iman A. Khaled. "EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS". EKB Journal Management System, 20, 4, 2001, 722-728. doi: 10.21608/ejsur.2001.375850
El Batanouny, M., M. Essawy, M., Ezzat, H., Abbas, M., M. Nosseir, M., S. Omran, Z., A. Khaled, I. (2001). 'EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS', EKB Journal Management System, 20(4), pp. 722-728. doi: 10.21608/ejsur.2001.375850
El Batanouny, M., M. Essawy, M., Ezzat, H., Abbas, M., M. Nosseir, M., S. Omran, Z., A. Khaled, I. EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS. EKB Journal Management System, 2001; 20(4): 722-728. doi: 10.21608/ejsur.2001.375850

EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS

The Egyptian Journal of Surgery
Article 4, Volume 20, Issue 4, October 2001, Page 722-728  XML PDF (439.58 K)
Document Type: Original Article
DOI: 10.21608/ejsur.2001.375850
View on SCiNiTO View on SCiNiTO
Authors
M El Batanouny1; Mohamed M. Essawy* 2; Hussein Ezzat2; Mohamed Abbas2; Mona M. Nosseir3; Zainab S. Omran3; Iman A. Khaled4
1General Surgery Department of Kasr El-Aini, Cairo University, Egypt.
2General Surgery, Theodor Bilharz Research Institute
3Pathology, Theodor Bilharz Research Institute
4Hematology Departments, Theodor Bilharz Research Institute
Abstract
This study was designed to assess the role of the spleen on the presence and localization of liver fibronectin, to measure 
the amount of hepatic collagen and serum level of fibronectin and procollagen III in cases of portal hypertension. 
The study was performed on 40 patients divided into two groups: Portal hypertension group (20 patients) included one 
pure schistosomal hepatic fibrosis, three mixed schistsomal and virus C cirrhosis, ten virus C hepatic cirrhosis, two virus B 
hepatic cirrhosis and four mixed B&C infections. Control group (20 patients) presented with different splenic insults without hepatic affection. In the first group, through clinical examinations and sonographic findings revealed hepatosplenomegaly and grade III & IV varices with history of injection sclerotherapy in 65% of cases. 
Preoperatively, marked hepatic fibronectin deposition in portal tracts and around blood vessels raised the stage of 
fibrosis. This was accompanied by decrease in plasma level of fibronectin and increase of serum level of procollagen III in 
relation to the control group. 
Six months post-operatively, tissue fibronectin, collagen content and serum procollagen III were insignificantly 
decreased. However, plasma level of fibronectin was increased significantly. 
These results denoted that fibronectin is one of the predominant early fibrogenic components in chronic liver diseases, 
stimulating further collagen deposition. It is concluded that the role of the spleen in the development of hepatic fibrosis seems ancillary. Multifactorial influences, including etiology, timing of splenectomy, hepatic vascular adjustment, and factors associated with the biology of extracellular matrix of the liver, probably play a more significant role. Further studies were recommended to assess the role of splenectomy on liver fibrogensis at different stages of fibrosis. Intervention with splenectomy could improve or reverse fibrogenic activity at early stages. 
Keywords
Splenectomy; fibrogenicity; fibronectin; procollagen III; liver fibrosis; portal hypertension
Statistics
Article View: 73
PDF Download: 33